EMILY SALDANA: Open Payments
NPI 1013342062 · HOPKINSVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,408 in 63 payments from 12 companies in 2025. Trend: 2023 $17 · 2024 $917 · 2025 $1,408
Food & beverage: $1,208Education: $200
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 14 | $570 |
| Amgen Inc. | 8 | $193 |
| Galderma Laboratories, L.P. | 19 | $151 |
| Lilly USA, LLC | 5 | $116 |
| GENZYME CORPORATION | 2 | $78 |
| UCB, Inc. | 3 | $72 |
| Regeneron Healthcare Solutions, Inc. | 3 | $56 |
| ABBVIE INC. | 3 | $51 |
| PFIZER INC. | 2 | $44 |
| Novartis Pharmaceuticals Corporation | 2 | $42 |
Products named: TREMFYA, Otezla, NEMLUVIO, DUPIXENT, TALTZ, Bimzelx, SKYRIZI, CIBINQO.
Industry payments across KY — which companies pay providers there.
